With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...

Astellas Pharma and Yaskawa Electric Corporation have formalized a development deal signed last year that will see the two Japanese companies partner to create an ...

Pressure to make cell and gene therapies more affordable will force the industry to overcome its reticence and embrace closed production systems, automation, and artificial intelligence (AI). So says, ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

According to Germany’s Federal Ministry for Economic Affairs and Climate Action, battery cells are gaining in importance as a versatile and efficient means of storing energy. They are a driving force ...